2013Chinese Medical Journal of Metallurgical IndustryRequires access

The eftreet of Rbesartan on the serum cysteine-C level in patients with diabetic nephropathy

Xia Xiao

Open publisher page 0 citations

Abstract

Objective To explore the effect of rbesartan on the serum Cysteine C(CysC)level in patients with diabetic nephropathy.Methods A prospective case-control study of patients with diabetic nephropathy who were ulldel-well glyeemie control,comparing those who had received 24 weeks of Rbesartan(N=40)to those without Rbesartan (N=40).Comparisons were made by measuring the changes of the eysteine-C level serum.Results Rbesartan treated patients had significantly depressed CysC level(P0.01),while the changes in CysC level of the control group had no statistical difference.Conclusion Rbesartan could lower the serum CysteineC(CysC)level in patients with diabetic nephropathy.

About this research paper

What this paper is about

Objective To explore the effect of rbesartan on the serum Cysteine C(CysC)level in patients with diabetic nephropathy.Methods A prospective case-control study of patients with diabetic nephropathy who were ulldel-well glyeemie control,comparing those who had received 24 weeks of Rbesartan(N=40)to those without Rbesartan (N=40).Comparisons were made by measuring the changes of the eysteine-C level serum.Results Rbesartan treated patients had significantly depressed CysC level(P0.01),while the changes in CysC level of the control group had no statistical difference.Conclusion Rbesartan could lower the serum CysteineC(CysC)level in patients with diabetic nephropathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the effect of rbesartan on the serum Cysteine C(CysC)level in patients with diabetic nephropathy.Methods A prospective case-control study of patients with diabetic nephropathy who were ulldel-well glyeemie control,comparing those who had received 24 weeks of Rbesartan(N=40)to those without Rbesartan (N=40).Comparisons were made by measuring the changes of the eysteine-C level serum.Results Rbesartan treated patients had significantly depressed CysC level(P0.01),while the changes in CysC level of the control group had no statistical difference.Conclusion Rbesartan could lower the serum CysteineC(CysC)level in patients with diabetic nephropathy.

Key concepts: Medicine, Diabetic nephropathy, Nephropathy, Internal medicine, Gastroenterology, Diabetes mellitus, Endocrinology, Urology

Related papers

Back to paper searchBrowse research topicsOriginal source
The eftreet of Rbesartan on the serum cysteine-C level in patients with diabetic nephropathy — Research Paper | ScholarLens